Acceleration of pharmaceutical production by using micro-reactor technology in a continuous mode by Mitic, Aleksandar et al.
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
General rights 
Copyright and moral rights for the publications made accessible in the public portal are retained by the authors and/or other copyright owners 
and it is a condition of accessing publications that users recognise and abide by the legal requirements associated with these rights. 
 
• Users may download and print one copy of any publication from the public portal for the purpose of private study or research. 
• You may not further distribute the material or use it for any profit-making activity or commercial gain 
• You may freely distribute the URL identifying the publication in the public portal  
 
If you believe that this document breaches copyright please contact us providing details, and we will remove access to the work immediately 
and investigate your claim. 
   
 
Downloaded from orbit.dtu.dk on: Dec 20, 2017
Acceleration of pharmaceutical production by using micro-reactor technology in a
continuous mode
Mitic, Aleksandar; Cervera Padrell, Albert Emili; Skovby, Tommy; Kiil, Søren; Gani, Rafiqul; Dam-
Johansen, Kim; Gernaey, Krist V.
Publication date:
2012
Link back to DTU Orbit
Citation (APA):
Mitic, A., Cervera Padrell, A. E., Skovby, T., Kiil, S., Gani, R., Dam-Johansen, K., & Gernaey, K. (2012).
Acceleration of pharmaceutical production by using micro-reactor technology in a continuous mode. Paper
presented at 12th International Conference on Microreaction Technology, Lyon, France.
Acceleration of Pharmaceutical Production by Using Micro-reactor 
Technology in a Continuous Mode   
Aleksandar Mitic1,*, Albert E. Cervera-Padrell1, Tommy Skovby2, Søren Kiil1, Rafiqul 
Gani1, Kim Dam-Johansen1 and Krist V. Gernaey1  
1 Department of Chemical and Biochemical Engineering, Technical University of Denmark, 
Søltofts Plads, Building 229, 2800  Kgs. Lyngby, Denmark 
2 H Lundbeck A/S, Oddenvej 182, Lumsås, 4500 Nykøbing Sjælland, Denmark 
*E-mail:asmi@kt.dtu.dk 
 
 
INTRODUCTION 
 
Organic synthesis is essential for the production of an important class of 
pharmaceuticals. However, once a production route has been established in the 
development lab, the subsequent implementation of organic synthesis on an 
industrial scale is still a great challenge. Traditionally, pharmaceutical manufacturing 
is mainly based on batch and semi-batch processes. However, besides flexibility and 
versatility of batch vessels, there are also many disadvantages connected with batch 
production. Furthermore, Process Analytical Technology (PAT) cannot reach the full 
benefits in this type of production system. Moving from batch to continuous 
production mode might offer a solution to those problems. Considering the relatively 
low production volumes in the pharmaceutical industry, the focus in a continuous 
production system is automatically directed towards small scale or even micro-scale 
equipment for reaction, separation etc.  
  
PROCESS DESCRIPTION 
 
The synthesis of cis-zuclopenthixol – a product of H. Lundbeck A/S – is studied. The 
manufacturing process consists of the process steps described in Figure 1. The 
paper will have focus on the experience gained with some of those steps, and will 
illustrate how a batch production system was converted into a continuous system. 
 
 
 
 
Figure 1: Schematic description of the production process (CTX - 2-Chlorthioxanthen-9-one;                 
GR - Allyl magnesium chloride; THF - Tetrahydrofuran; Alkoxidation – intermediate; 
Allylcarbinol - 9-Allyl-2-Chlorothioxanthen-9-Ol-9H-thioxanthen-9-ol-2-chloro-9-(2-propenyl)-
(9CI); Butadiene - 9H-Thioxanthene-2-chloro-9-(2-propenylidene)-(9CI) ; HEP - 2-(1-
piperazinyl)ethanol) 
Grignard alkylation 
 
A mini-reactor is used to perform the Grignard alkylation of CTX. Impurity formation in 
this step was kept low due to the development of a feedback controller that uses on-
line near infrared (NIR) spectroscopy data to titrate the CTX with Grignard reagent. 
Thanks to an improvement of mass and heat transfer in the mini-reactor, combined 
with more accurate dosing of the Grignard reagent, formation of by-products has 
been drastically decreased.  
 
Liquid-liquid separation 
 
After hydrolysis of the product obtained in the alkylation reaction, it is necessary to 
separate the organic (THF-allylcarbinol) and aqueous phases (water containing Mg 
salts). The presence of inorganic salts significantly affects the solubility of THF in 
water due to the salting-out effect. The two solvents, which under normal 
circumstances are totally miscible, separate into an aqueous and an organic phase. 
The salting-out effect is further increased by the addition of acid which dissolves the 
basic magnesium salts in the solution. In our case study the phases have similar 
densities, and therefore a PTFE membrane mini-separator based on capillarity and 
surface tension differences [1] has been developed and tested. Different immiscible 
liquid mixtures have been examined and the efficiency achieved with this separation 
method is very high.  
                 
Hydroamination reaction 
 
One of the major practical problems when switching an organic synthesis-based 
process from batch to continuous operation is that not all reactions are suited to be 
operated in continuous mode. Hence, in the example process the slow 
hydroamination step has to be accelerated. Possible solutions could be chemical 
catalysts for intermolecular anti-Markovnikov hydroamination [2-3]. Hence, different 
catalysts are to be tested. Furthermore, micro-scale technology as well as microwave 
heating will be investigated, too.  
 
CONCLUSIONS 
 
Micro-scale technology can be extremely helpful when establishing a continuous 
pharmaceutical production process, as illustrated here for the zuclopenthixol 
synthesis process. However, not all reactions can be operated in a straightforward 
way at micro-scale. As illustrated for the case study efficient process development 
might result in a combination of unit operations at the micro-scale on the one hand, 
and liter scale reactors on the other hand.  
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